IONIS PHARMACEUTICALS INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Ionis Pharmaceuticals Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2010 to Q4 2023.
  • Ionis Pharmaceuticals Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $978M, a 20.9% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $978M +$169M +20.9% Dec 31, 2023 10-K 2024-02-21
Q4 2022 $809M +$111M +15.9% Dec 31, 2022 10-K 2024-02-21
Q4 2021 $698M +$39M +5.92% Dec 31, 2021 10-K 2023-02-22
Q4 2020 $659M +$462M +234% Dec 31, 2020 10-K 2022-02-25
Q4 2019 $197M -$37.3M -15.9% Dec 31, 2019 10-K 2021-02-24
Q4 2018 $234M -$234M -50% Dec 31, 2018 10-K 2020-03-02
Q4 2017 $469M +$16.5M +3.66% Dec 31, 2017 10-K 2019-03-01
Q4 2016 $452M +$48.1M +11.9% Dec 31, 2016 10-K 2018-02-28
Q4 2015 $404M +$88.2M +27.9% Dec 31, 2015 10-K 2017-03-01
Q4 2014 $316M -$26.3M -7.69% Dec 31, 2014 10-K 2016-02-26
Q4 2013 $342M +$28.9M +9.21% Dec 31, 2013 10-K 2015-03-02
Q4 2012 $313M +$5.92M +1.92% Dec 31, 2012 10-K 2014-03-03
Q4 2011 $307M +$41.6M +15.7% Dec 31, 2011 10-K 2013-02-28
Q4 2010 $266M Dec 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.